The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
- PMID: 26030634
- DOI: 10.7326/M14-2385
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
Abstract
The PRISMA statement is a reporting guideline designed to improve the completeness of reporting of systematic reviews and meta-analyses. Authors have used this guideline worldwide to prepare their reviews for publication. In the past, these reports typically compared 2 treatment alternatives. With the evolution of systematic reviews that compare multiple treatments, some of them only indirectly, authors face novel challenges for conducting and reporting their reviews. This extension of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement was developed specifically to improve the reporting of systematic reviews incorporating network meta-analyses. A group of experts participated in a systematic review, Delphi survey, and face-to-face discussion and consensus meeting to establish new checklist items for this extension statement. Current PRISMA items were also clarified. A modified, 32-item PRISMA extension checklist was developed to address what the group considered to be immediately relevant to the reporting of network meta-analyses. This document presents the extension and provides examples of good reporting, as well as elaborations regarding the rationale for new checklist items and the modification of previously existing items from the PRISMA statement. It also highlights educational information related to key considerations in the practice of network meta-analysis. The target audience includes authors and readers of network meta-analyses, as well as journal editors and peer reviewers.
Comment in
-
The PRISMA extension for network meta-analysis: bringing clarity and guidance to the reporting of systematic reviews incorporating network meta-analyses.Ann Intern Med. 2015 Jun 2;162(11):797-8. doi: 10.7326/M15-0930. Ann Intern Med. 2015. PMID: 26030637 No abstract available.
-
The PRISMA Extension Statement.Ann Intern Med. 2015 Oct 6;163(7):566. doi: 10.7326/L15-5144. Ann Intern Med. 2015. PMID: 26436628 No abstract available.
-
The PRISMA Extension Statement.Ann Intern Med. 2015 Oct 6;163(7):566-7. doi: 10.7326/L15-5144-2. Ann Intern Med. 2015. PMID: 26436629 No abstract available.
Similar articles
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.J Clin Epidemiol. 2009 Oct;62(10):e1-34. doi: 10.1016/j.jclinepi.2009.06.006. Epub 2009 Jul 23. J Clin Epidemiol. 2009. PMID: 19631507
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.Ann Intern Med. 2009 Aug 18;151(4):W65-94. doi: 10.7326/0003-4819-151-4-200908180-00136. Epub 2009 Jul 20. Ann Intern Med. 2009. PMID: 19622512
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.BMJ. 2009 Jul 21;339:b2700. doi: 10.1136/bmj.b2700. BMJ. 2009. PMID: 19622552 Free PMC article.
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.PLoS Med. 2009 Jul 21;6(7):e1000100. doi: 10.1371/journal.pmed.1000100. Epub 2009 Jul 21. PLoS Med. 2009. PMID: 19621070 Free PMC article.
-
Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.J Clin Epidemiol. 2016 Feb;70:68-89. doi: 10.1016/j.jclinepi.2015.09.001. Epub 2015 Sep 5. J Clin Epidemiol. 2016. PMID: 26348799
Cited by
-
Combined traditional Chinese medicine and anti-hypertensive treatments for renal hypertension: A network meta-analysis and systematic review.Medicine (Baltimore). 2024 Oct 4;103(40):e39793. doi: 10.1097/MD.0000000000039793. Medicine (Baltimore). 2024. PMID: 39465780 Free PMC article.
-
Antiemetic medications for preventing chemotherapy-induced nausea and vomiting in children: a systematic review and Bayesian network meta-analysis.Support Care Cancer. 2024 Oct 27;32(11):747. doi: 10.1007/s00520-024-08939-9. Support Care Cancer. 2024. PMID: 39465444 Free PMC article. Review.
-
Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists.Pharmaceutics. 2024 Oct 8;16(10):1310. doi: 10.3390/pharmaceutics16101310. Pharmaceutics. 2024. PMID: 39458639 Free PMC article.
-
Stem Cells: Present Understanding and Prospects for Regenerative Dentistry.J Funct Biomater. 2024 Oct 15;15(10):308. doi: 10.3390/jfb15100308. J Funct Biomater. 2024. PMID: 39452606 Free PMC article. Review.
-
Efficacy of swallowing rehabilitative therapies for adults with dysphagia: a network meta-analysis of randomized controlled trials.Geroscience. 2024 Oct 23. doi: 10.1007/s11357-024-01389-5. Online ahead of print. Geroscience. 2024. PMID: 39438392
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous